TherapeuticsMD, Inc. (TXMD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 18.86M |
| Enterprise Value | 17.47M |
| P/E Ratio | -114.44 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 7.29 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 6.18 |
| Enterprise/EBITDA | -4.82 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.07 |
| Operating Margin | -1.18 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 3.02M |
| Revenue/Share | 282.53 |
| Gross Profit | 3.02M |
| EBITDA | -3.02M |
| Net Income | -569,000 |
| Diluted EPS | -0.05 |
Balance Sheet
| Total Cash | 9.19M |
| Total Cash/Share | 793.93 |
| Total Debt | 5.56M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 3.22 |
| Book Value Per Share | 2,344.22 |
Price History
| 52-Week Change | 87.27 |
| 52-Week High | 2.95 |
| 52-Week Low | 0.99 |
| Moving Average 50 Days | 2.06 |
| Moving Average 200 Days | 2.03 |
Statistics
| Average Volume | 38,217 |
| Shares Outstanding | 11.57M |
| % Held by Institutions | 33.96 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | May 09, 2022 |
AD
